8-K Announcements
6Material company update
May 5, 2026·SEC
Material company update
Apr 13, 2026·SEC
Material company update
Feb 24, 2026·SEC
AdaptHealth Corp.(AHCO)Earnings, Financials & Key Ratios
AHCO•NASDAQ
$10.60
Price updated Jul 2, 2026
AboutAdaptHealth Corp., together with its subsidiaries, provides home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps to patients for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It serves beneficiaries of Medicare, Medicaid, and commercial insurance payors. AdaptHealth Corp. is headquartered in Plymouth Meeting, Pennsylvania.Show more
- Revenue$3.24B-0.5%
- EBITDA$599M-4.7%
- Net Income-$71M-178.3%
- EPS (Diluted)-0.52-185.2%
- Gross Margin17.52%-16.1%
- EBITDA Margin18.47%-4.3%
- Operating Margin5.74%-29.0%
- Net Margin-2.18%-178.7%
- ROE-4.56%-176.8%
AHCO Price & Volume
AdaptHealth Corp. (AHCO) stock price & volume — 10-year historical chart
Loading chart...
Volatile Revenue Growth Masks Structural Margin Instability
Investment Thesis • Updated 2026Q1
VerdictNegative
Growth:Mixed
Profitability:Negative
Financial:Strained
Cash Flow:Mixed
Primary Risk:Regulatory Reimbursement Compression
Key Thesis Takeaways
- AdaptHealth faces a challenging outlook characterized by inconsistent organic growth and significant reliance on inorganic acquisitions, as evidenced by goodwill comprising 59% of total assets.
- While the company recently reduced its debt from $1.9B in 2025Q4 to $201.8M in 2026Q1, the persistent erosion of shareholder equity, reflected in negative retained earnings of $649.0M, raises concerns regarding long-term solvency.
- Investors should remain cautious as the firm struggles to convert its $819.8M in 2026Q1 revenue into stable operating income, which currently sits at a thin 0.7% margin.
Verdict Logic
the company's inability to maintain consistent profitability, evidenced by a -2.0% net margin in 2026Q1 and a history of erratic earnings, suggests significant execution risk for shareholders.
AHCO Growth Metrics
AdaptHealth Corp. (AHCO) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years25.16%
3 Years2.99%
TTM8.78%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-193.3%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-203.51%
Return on Capital
10 Years2.51%
5 Years1.86%
3 Years-0.69%
Last Year4.95%
AHCO Recent Earnings
AdaptHealth Corp. (AHCO) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 4/12 qtrs (33%)●Beat Revenue 9/12 qtrs (75%)
Q2 2026Latest
May 5, 2026Metric
Actual
Est
EPS
$0.06-580.0%
$0.01
Rev
$820M+2.9%
$797M
Q1 2026
Feb 24, 2026Metric
Actual
Est
EPS
$0.27-20.6%
$0.34
Rev
$846M+1.8%
$832M
Q4 2025
Nov 4, 2025Metric
Actual
Est
EPS
$0.22-8.3%
$0.24
Rev
$820M-1.5%
$833M
Q3 2025
Aug 5, 2025Metric
Actual
Est
EPS
$0.01-93.3%
$0.15
Rev
$800M+0.2%
$799M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 5, 2026 | $0.06vs $0.01-580.0% | $820Mvs $797M+2.9% |
| Q1 2026 | Feb 24, 2026 | $0.27vs $0.34-20.6% | $846Mvs $832M+1.8% |
| Q4 2025 | Nov 4, 2025 | $0.22vs $0.24-8.3% | $820Mvs $833M-1.5% |
| Q3 2025 | Aug 5, 2025 | $0.01vs $0.15-93.3% | $800Mvs $799M+0.2% |
Based on last 12 quarters of dataView full earnings history →
Peers Comparison
Key metrics vs top competitors for AdaptHealth Corp. (AHCO)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $10.60 | $1.44B | -20.38 | -0.49% | -2.18% | -4.56% | — | |
| $25.11 | $1.72B | 31.00 | 7.08% | 3.67% | 13.6% | — | |
| $21.04 | $3.29B | 16.57 | 13.03% | 3.64% | 15.28% | — | |
| $13.80 | $706.91M | -152.32 | 2.44% | -0.3% | -0.55% | — | |
| $81.35 | $6.75B | 10.46 | 114.51% | -22.58% | — | — | |
| $27.20 | $25.89B | 25.66 | -1.04% | 5.49% | 8.96% | — |
Compare AHCO vs Peers
AdaptHealth Corp. (AHCO) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
AHCO SEC Filings & Documents
AdaptHealth Corp. (AHCO) SEC filings — annual & quarterly reports (10-K, 10-Q)
Get notified when AHCO posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
AHCO Frequently Asked Questions
AdaptHealth Corp. (AHCO) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
What is AdaptHealth Corp.'s revenue?
AdaptHealth Corp. (AHCO) reported $2.86B in revenue for fiscal year 2025. This represents a 1386% increase from $192.6M in 2017.
How fast is AdaptHealth Corp. growing?
AdaptHealth Corp. (AHCO) saw revenue decline by 0.5% over the past year.
Is AHCO profitable?
AdaptHealth Corp. (AHCO) reported a net loss of $79.6M for fiscal year 2025.
Dividend & Returns
What is AHCO's return on equity?
AdaptHealth Corp. (AHCO) has a return on equity (ROE) of -4.6%. Negative ROE indicates the company is unprofitable.
What is AdaptHealth Corp.'s free cash flow?
AdaptHealth Corp. (AHCO) generated $219.4M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.